This inventor holds 1 USPTO granted patent. Top assignees: Cornell University, Sloan-Kettering Institute for Cancer Research. Active years: 1999.
Company Filing History:
1 out of 2,949 
1 out of 519 
Years Active: 1999
Title: Felix Grun: Innovator in Retinol Dehydratase Research
Introduction
Felix Grun is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of biochemistry, particularly in the study of retinol dehydratase. His work has implications for understanding cell growth and potential treatments for related conditions.
Latest Patents
Felix Grun holds a patent for the isolation, purification, and cloning of retinol dehydratase. This invention relates to the enzyme that synthesizes the retro-retinoid anhydroretinol in the Spodoptera frugiperda insect cell line Sf-21. The patent details the DNA molecule encoding this enzyme, which can be incorporated into a DNA expression system for recombinant production. The isolated retinol dehydratase protein can be combined with a pharmaceutically acceptable carrier for administration to mammals, particularly humans, to prevent uncontrolled cell growth in cells dependent on retinol.
Career Highlights
Throughout his career, Felix Grun has worked at prestigious institutions such as the Sloan-Kettering Institute for Cancer Research and Cornell University. His research has focused on the biochemical pathways involving retinol and its derivatives, contributing to advancements in cancer research and treatment.
Collaborations
Felix has collaborated with esteemed colleagues, including Jochen Buck and Ulrich Hammerling. These partnerships have enhanced the depth and impact of his research in the field.
Conclusion
Felix Grun's innovative work in the isolation and application of retinol dehydratase showcases his commitment to advancing scientific knowledge and potential therapeutic solutions. His contributions continue to influence the fields of biochemistry and cancer research.